-
Startseite
-
a-t-Inhaltsverzeichnis
-
a-t-Volltextsuche
für Nichtabonnenten
-
Bereich für Abonnenten
   blitz-a-t
   e a-t
   a-t-Volltextregister
   NETZWERK-UAW
   Leserpost
-
atd Arzneimitteldatenbank
-
Glossar
-
a-t englisch  
   Current issue
   Archive
-
Bestellungen
   arznei-telegramm
   Bücher, CD,
   Sammelmappen
   atd
   Arzneimitteldatenbank
   Mitteilung
   an den Vertrieb
-
Wir über uns
-
Impressum
-
Datenschutz
-
 
 
  Volume 35, 20 August 2004 8/2004
 
  SPOT ON
 

Ministry of Health slows down establishment of new reference price groups
Varicella vaccination for all infants?

 
  NEW ON THE MARKET
 

Antipsychotic agent aripiprazole (ABILIFY)

 
  THERAPIES FROM A CRITICAL VIEW POINT
 

Treatment of chronic hepatitis C in patients with HIV coinfection
Implantable cardioverter-defibrillators in heart failure?

 
  a-t READERS' QUESTIONS AND COMMENTS
 

Antiparkinson drug ALMIRID (dihydroergocriptine): advertisement by postcards
Carcinogenicity of insulin analogues
Antidepressant JATROSOM N (Tranylcypromin): price rise
"Bowel decontamination" for chronic urticaria?

 
  IN BRIEF
 

Once more: clopidogrel (ISCOVER, PLAVIX) plus aspirin after stroke
10 months too late: market-withdrawal of CASODEX 150 mg
Pravastatin (e.g. PRAVASIN): additional generics
Influenza vaccines 2004/2005

 
  CURRENT ADR NETWORK REPORT

Naftidrofuryl-induced liver damage

 
© arznei-telegramm 8/2004